Idelalisib in Combination With Rituximab or Bendamustine or Both in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
暂无分享,去创建一个
J. Leonard | I. Flinn | S. de Vos | K. Rai | S. Coutre | R. Furman | S. Mitra | Yeonhee Kim | N. Fowler | J. Sharman | J. Barrientos | M. Schreeder | L. Dreiling | T. Boyd | Nina Wagner-Johnson